What is the recommended adult dose of chlorzoxazone, and how should it be adjusted for elderly patients or those with hepatic impairment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Chlorzoxazone Dosing

The recommended adult dose of chlorzoxazone is 250-500 mg three to four times daily initially, with a maximum of 750 mg three to four times daily if needed; elderly patients and those with hepatic impairment should start at the lower end of the dosing range (250 mg three to four times daily) due to reduced drug clearance. 1

Standard Adult Dosing

According to FDA labeling, chlorzoxazone dosing depends on the tablet strength available 1:

  • Initial dose: 250-500 mg three to four times daily for painful musculoskeletal conditions
  • Maximum dose: 750 mg three to four times daily if adequate response is not obtained
  • Dose reduction: As improvement occurs, dosage should be reduced

The specific FDA-approved regimens are:

  • 375 mg tablets: Start with one tablet 3-4 times daily, may increase to two tablets (750 mg) 3-4 times daily
  • 500 mg tablets: Start with one tablet 3-4 times daily, may increase to 1.5 tablets (750 mg) 3-4 times daily
  • 750 mg tablets: Start with 1/3 tablet (250 mg) 3-4 times daily for initial therapy, or 2/3 tablet (500 mg) 3-4 times daily for painful conditions, may increase to one full tablet 3-4 times daily

Dose-Dependent Metabolism Considerations

Chlorzoxazone exhibits dose-dependent metabolism, meaning higher doses result in disproportionately higher drug exposure. Research demonstrates that a 750 mg dose produces a 30% increase in dose-normalized area under the curve compared to 250 mg, with reduced metabolite formation at higher doses 2, 3. This saturation of metabolism occurs because chlorzoxazone is primarily metabolized by CYP2E1, which becomes saturated at commonly used clinical doses.

Body weight also affects chlorzoxazone metabolism, with positive correlation between body weight and metabolic ratio 3. Heavier patients may require doses at the higher end of the range, while lighter patients should use lower doses to avoid excessive drug accumulation.

Elderly Patients

Elderly patients require dose reduction due to age-related changes in drug metabolism, though specific geriatric dosing guidelines are not established in the FDA label. 1

Key considerations for elderly patients:

  • Start at the lowest effective dose (250 mg three to four times daily)
  • Chlorzoxazone is listed in the 2019 AGS Beers Criteria as a muscle relaxant that should be avoided in older adults when possible due to anticholinergic effects, CNS adverse effects including sedation, and increased fall risk 4
  • Monitor closely for adverse effects including drowsiness, dizziness, and increased fall risk
  • The intra-individual variability in chlorzoxazone metabolism is relatively low (28-30%), but elderly patients may have reduced hepatic clearance 3

Hepatic Impairment

Chlorzoxazone should be used with extreme caution in patients with hepatic impairment and is contraindicated in severe hepatic dysfunction. 1

Specific precautions:

  • Discontinue immediately if any symptoms suggestive of liver dysfunction occur 1
  • The drug is metabolized primarily by hepatic CYP2E1, so impaired liver function will significantly reduce clearance
  • Start at the lowest dose (250 mg three to four times daily) and titrate cautiously
  • Monitor liver function tests if treatment is necessary in patients with mild-to-moderate hepatic impairment
  • Avoid use entirely in severe hepatic impairment (Child-Pugh score >9), consistent with general principles for hepatically-cleared muscle relaxants 5

Renal Impairment

The FDA label does not provide specific dosing adjustments for renal impairment 1. However, since chlorzoxazone is primarily hepatically metabolized rather than renally cleared, dose adjustment for renal impairment is generally not required unless severe renal failure is present.

Important Clinical Caveats

  • Allergic reactions: Use with caution in patients with known drug allergies; discontinue if urticaria, redness, or itching occurs 1
  • Duration of therapy: The FDA label does not specify maximum duration, but as a muscle relaxant for acute musculoskeletal conditions, treatment should be time-limited
  • Monitoring: Watch for signs of hepatotoxicity and allergic reactions; no routine laboratory monitoring is specified in the label
  • Drug interactions: Chlorzoxazone is metabolized by CYP2E1; ethanol and other CYP2E1 inducers or inhibitors may affect drug levels, though moderate ethanol intake the preceding evening does not significantly alter metabolism 3

References

5
Guideline

american association of clinical endocrinologists and american college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2016

Related Questions

Can I take chlorzoxazone while I am taking 2 mg of tizanidine?
For how long can chlorzoxazone (muscle relaxant) be used over-the-counter (OTC)?
How to use Chlorzoxazone (muscle relaxant)?
What is the appropriate dosing regimen of clarithromycin for pediatric patients, including dose, frequency, duration, and adjustments for hepatic or renal impairment?
Can Docetaxel or Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase) cause severe Impaired Renal Function?
In a patient with atrial fibrillation with rapid ventricular response who is already on oral metoprolol at home, is a 2.5 mg intravenous metoprolol (Lopressor) dose appropriate?
In a patient with a recent viral upper respiratory infection who now has right-sided cervical pain that worsens with swallowing and focal tenderness over the right neck, should the treatment be changed?
Is dexamethasone appropriate for treating trigeminal neuralgia pain?
How should I manage a patient with a pre‑void bladder volume of 360 mL and a post‑void residual of 285 mL?
How should agitation and altered sensorium caused by scopolamine be managed in an 80-year-old patient with Parkinson's disease?
Is it safe for a patient with a skull fracture sustained seven days ago to fly on Tuesday?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.